Entia Biosciences, Inc.
CIK 0001408299
Revenue (TTM)
$287.53K
−23.5% YoY
FY May 2017
Net Income (TTM)
−$1.33M
+38.2% YoY
FY May 2017
EPS Diluted (TTM)
—
FY May 2017
Gross Margin
64.2%
FY May 2017
Operating Margin
-437.7%
FY May 2017
Net Margin
-462.5%
FY May 2017
Free Cash Flow (TTM)
−$296.9K
FY May 2017
Cash
$76.05K
FY May 2017
Total Debt
$10K
FY May 2017
Shares Outstanding
33.66M sh
FY May 2017